Etilefrine in the treatment of levodopa-induced orthostatic hypotension.

E. Miller,L. Wiener,D. Bloomfield
DOI: https://doi.org/10.1001/ARCHNEUR.1973.00490260043008
1973-08-01
Archives of Neurology
Abstract:Fifteen patients who developed postural hypotension during levodopa therapy for Parkinson's disease were treated with etilefrine hydrochloride in a single-blind study. A placebo-treated group served as control. Fourteen of the 15 etilefrine-treated patients responded favorably. Before treatment, the mean drop in systolic pressure when assuming upright position was 26.3%; after treatment with 15 mg etilefrine daily, the drop was only 4.3%. The mean diastolic pressure drop prior to treatment averaged 14.2%, compared to 1.2% after treatment. Eighty-six percent of symptoms related to postural hypotension were alleviated. No side effects or laboratory abnormalities were encountered.
What problem does this paper attempt to address?